Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Aerska, a Dublin-based biotechnology startup, raised €32 million in Series A funding led by EQT Dementia Fund and age1 to advance its RNA medicine platform.

PRIVATESep 01, 2026•5 days ago

Amount Raised

€32 Million

Round Type

Series A

DublinBiotechnologyHealth CareMedicalTherapeutics

Investors

Age1Eqt Dementia Fund

Description

Founded in 2025, Aerska is developing RNA-based medicines designed to treat neurological diseases. Earlier this year, the company secured €32 million in Series A funding to advance its RNA medicine platform and move its neurological programmes towards clinical development.

Company Information

Company

Aerska

Location

Dublin, Dublin, Ireland

About

Aerska is a biotechnology company developing RNA medicines to treat, delay, and prevent diseases of the brain. The company is leveraging advances in ‘brain shuttles’ to enable targeted delivery of next-generation RNAi therapeutics to the CNS. Aerska is headquartered in Dublin, Ireland, with research operations in London, UK.

Don't miss Aerska's next move

Get an email the moment Aerska raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
2 contacts
Verified contactsJack O., CEO, Co-founder hidden hidden
Predictive Intelligence
Strategic

ML-powered predictions for Aerska's next move

See what Strategic adds

Funding Insights

Based on industry data
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Aerska raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.